Ticker Details
Insulet Corporation Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
IPO Date:	May 15, 2007
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$17.02B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.77 | 1.89%
Avg Daily Range (30 D):	$3.90 | 1.48%
Avg Daily Range (90 D):	$4.41 | 1.48%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	.95M
Avg Daily Volume (90 D):	.66M

Trade Size
Avg Trade Size (Sh.):	66
Avg Trade Size (Sh.) (30 D):	31
Avg Trade Size (Sh.) (90 D):	27

Institutional Trades
Total Institutional Trades:	10,026
Avg Institutional Trade:	$6.11M
Avg Institutional Trade (30 D):	$13.77M
Avg Institutional Trade (90 D):	$17.31M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$10.97M
Avg Closing Trade (30 D):	$32.24M
Avg Closing Trade (90 D):	$32.05M
Avg Closing Volume:	57.94K

News

Feb 13, 2026 @ 4:26 PM Accessible Health Platforms Gain Scale Across $6T ... Source: Prnewswire

Jan 19, 2026 @ 2:00 PM BVI Appoints Jim Hollingshead as President & Chief... Source: David Chavez

Aug 7, 2025 @ 5:50 PM Insulet Peer Tandem Diabetes Underwhelming Earning... Source: Vandana Singh

Aug 7, 2025 @ 5:08 PM Insulet Lifts Annual Forecast On Increased Adoptio... Source: Vandana Singh

Jul 31, 2025 @ 2:00 PM Diabetes Care Devices Market Size Projects USD 76.... Source: Towards Healthcare

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.51	$1.44	$3.51
Diluted EPS	$3.48	$1.43	$3.48
Revenue	$2.71B	$783.8M	$2.71B
Gross Profit	$1.94B	$568.6M	$1.94B
Net Income / Loss	$247.1M	$101.6M	$247.1M
Operating Income / Loss	$473.8M	$146.3M	$473.8M
Cost of Revenue	$768.2M	$215.2M	$768.2M
Net Cash Flow	$-237.2M	$-41.3M	$-237.2M
PE Ratio	70.47